

Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.
Highlights
The global Immunoprecipitation Testing market was valued at US$ 528.7 million in 2022 and is anticipated to reach US$ 772.5 million by 2029, witnessing a CAGR of 5.5% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
The classification of Immunoprecipitation Testing includes Individual Protein Immunoprecipitation, Co-Immunoprecipitation (Co-IP), Chromatin Immunoprecipitation (ChIP), RNA Immunoprecipitation (RIP) and others. The proportion of Individual Protein Immunoprecipitation in 2019 is about34%, the proportion of Co-Immunoprecipitation (Co-IP) is 26% in 2019.
Immunoprecipitation Testing is widely used in Academic & Research Institutes, Pharmaceutical Companies and Contract Research Organizations. The most proportion of Immunoprecipitation Testing is Academic & Research Institutes, and the sales proportion in 2019 is 51%.
North America is the largest consumption place, with a consumption market share nearly 43% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is intense. Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GenScript, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immunoprecipitation Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoprecipitation Testing.
The Immunoprecipitation Testing market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Immunoprecipitation Testing market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunoprecipitation Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Thermo Fischer Scientific
Merck
GenScript
Bio-Techne
BioLegend
Takara Bio
Abcam
Rockland Immunochemicals
Cell Signaling Technology
Geno Technology
Segment by Type
Individual Protein Immunoprecipitation
Co-Immunoprecipitation (Co-IP)
Chromatin Immunoprecipitation (ChIP)
RNA Immunoprecipitation (RIP)
Others
Segment by Application
Academic & Research Institutes
Pharmaceutical Companies
Contract Research Organizations
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immunoprecipitation Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immunoprecipitation Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Immunoprecipitation Testing Market Overview
1.1 Product Overview and Scope of Immunoprecipitation Testing
1.2 Immunoprecipitation Testing Segment by Type
1.2.1 Global Immunoprecipitation Testing Market Value Comparison by Type (2023-2029)
1.2.2 Individual Protein Immunoprecipitation
1.2.3 Co-Immunoprecipitation (Co-IP)
1.2.4 Chromatin Immunoprecipitation (ChIP)
1.2.5 RNA Immunoprecipitation (RIP)
1.2.6 Others
1.3 Immunoprecipitation Testing Segment by Application
1.3.1 Global Immunoprecipitation Testing Market Value by Application: (2023-2029)
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Contract Research Organizations
1.4 Global Immunoprecipitation Testing Market Size Estimates and Forecasts
1.4.1 Global Immunoprecipitation Testing Revenue 2018-2029
1.4.2 Global Immunoprecipitation Testing Sales 2018-2029
1.4.3 Global Immunoprecipitation Testing Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Immunoprecipitation Testing Market Competition by Manufacturers
2.1 Global Immunoprecipitation Testing Sales Market Share by Manufacturers (2018-2023)
2.2 Global Immunoprecipitation Testing Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Immunoprecipitation Testing Average Price by Manufacturers (2018-2023)
2.4 Global Immunoprecipitation Testing Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Immunoprecipitation Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immunoprecipitation Testing, Product Type & Application
2.7 Immunoprecipitation Testing Market Competitive Situation and Trends
2.7.1 Immunoprecipitation Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immunoprecipitation Testing Players Market Share by Revenue
2.7.3 Global Immunoprecipitation Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immunoprecipitation Testing Retrospective Market Scenario by Region
3.1 Global Immunoprecipitation Testing Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Immunoprecipitation Testing Global Immunoprecipitation Testing Sales by Region: 2018-2029
3.2.1 Global Immunoprecipitation Testing Sales by Region: 2018-2023
3.2.2 Global Immunoprecipitation Testing Sales by Region: 2024-2029
3.3 Global Immunoprecipitation Testing Global Immunoprecipitation Testing Revenue by Region: 2018-2029
3.3.1 Global Immunoprecipitation Testing Revenue by Region: 2018-2023
3.3.2 Global Immunoprecipitation Testing Revenue by Region: 2024-2029
3.4 North America Immunoprecipitation Testing Market Facts & Figures by Country
3.4.1 North America Immunoprecipitation Testing Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Immunoprecipitation Testing Sales by Country (2018-2029)
3.4.3 North America Immunoprecipitation Testing Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immunoprecipitation Testing Market Facts & Figures by Country
3.5.1 Europe Immunoprecipitation Testing Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Immunoprecipitation Testing Sales by Country (2018-2029)
3.5.3 Europe Immunoprecipitation Testing Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immunoprecipitation Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Immunoprecipitation Testing Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Immunoprecipitation Testing Sales by Country (2018-2029)
3.6.3 Asia Pacific Immunoprecipitation Testing Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immunoprecipitation Testing Market Facts & Figures by Country
3.7.1 Latin America Immunoprecipitation Testing Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Immunoprecipitation Testing Sales by Country (2018-2029)
3.7.3 Latin America Immunoprecipitation Testing Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immunoprecipitation Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Immunoprecipitation Testing Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Immunoprecipitation Testing Sales by Country (2018-2029)
3.8.3 Middle East and Africa Immunoprecipitation Testing Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immunoprecipitation Testing Sales by Type (2018-2029)
4.1.1 Global Immunoprecipitation Testing Sales by Type (2018-2023)
4.1.2 Global Immunoprecipitation Testing Sales by Type (2024-2029)
4.1.3 Global Immunoprecipitation Testing Sales Market Share by Type (2018-2029)
4.2 Global Immunoprecipitation Testing Revenue by Type (2018-2029)
4.2.1 Global Immunoprecipitation Testing Revenue by Type (2018-2023)
4.2.2 Global Immunoprecipitation Testing Revenue by Type (2024-2029)
4.2.3 Global Immunoprecipitation Testing Revenue Market Share by Type (2018-2029)
4.3 Global Immunoprecipitation Testing Price by Type (2018-2029)
5 Segment by Application
5.1 Global Immunoprecipitation Testing Sales by Application (2018-2029)
5.1.1 Global Immunoprecipitation Testing Sales by Application (2018-2023)
5.1.2 Global Immunoprecipitation Testing Sales by Application (2024-2029)
5.1.3 Global Immunoprecipitation Testing Sales Market Share by Application (2018-2029)
5.2 Global Immunoprecipitation Testing Revenue by Application (2018-2029)
5.2.1 Global Immunoprecipitation Testing Revenue by Application (2018-2023)
5.2.2 Global Immunoprecipitation Testing Revenue by Application (2024-2029)
5.2.3 Global Immunoprecipitation Testing Revenue Market Share by Application (2018-2029)
5.3 Global Immunoprecipitation Testing Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fischer Scientific
6.1.1 Thermo Fischer Scientific Corporation Information
6.1.2 Thermo Fischer Scientific Description and Business Overview
6.1.3 Thermo Fischer Scientific Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fischer Scientific Immunoprecipitation Testing Product Portfolio
6.1.5 Thermo Fischer Scientific Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Immunoprecipitation Testing Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 GenScript
6.3.1 GenScript Corporation Information
6.3.2 GenScript Description and Business Overview
6.3.3 GenScript Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GenScript Immunoprecipitation Testing Product Portfolio
6.3.5 GenScript Recent Developments/Updates
6.4 Bio-Techne
6.4.1 Bio-Techne Corporation Information
6.4.2 Bio-Techne Description and Business Overview
6.4.3 Bio-Techne Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio-Techne Immunoprecipitation Testing Product Portfolio
6.4.5 Bio-Techne Recent Developments/Updates
6.5 BioLegend
6.5.1 BioLegend Corporation Information
6.5.2 BioLegend Description and Business Overview
6.5.3 BioLegend Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BioLegend Immunoprecipitation Testing Product Portfolio
6.5.5 BioLegend Recent Developments/Updates
6.6 Takara Bio
6.6.1 Takara Bio Corporation Information
6.6.2 Takara Bio Description and Business Overview
6.6.3 Takara Bio Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Takara Bio Immunoprecipitation Testing Product Portfolio
6.6.5 Takara Bio Recent Developments/Updates
6.7 Abcam
6.6.1 Abcam Corporation Information
6.6.2 Abcam Description and Business Overview
6.6.3 Abcam Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abcam Immunoprecipitation Testing Product Portfolio
6.7.5 Abcam Recent Developments/Updates
6.8 Rockland Immunochemicals
6.8.1 Rockland Immunochemicals Corporation Information
6.8.2 Rockland Immunochemicals Description and Business Overview
6.8.3 Rockland Immunochemicals Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Rockland Immunochemicals Immunoprecipitation Testing Product Portfolio
6.8.5 Rockland Immunochemicals Recent Developments/Updates
6.9 Cell Signaling Technology
6.9.1 Cell Signaling Technology Corporation Information
6.9.2 Cell Signaling Technology Description and Business Overview
6.9.3 Cell Signaling Technology Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cell Signaling Technology Immunoprecipitation Testing Product Portfolio
6.9.5 Cell Signaling Technology Recent Developments/Updates
6.10 Geno Technology
6.10.1 Geno Technology Corporation Information
6.10.2 Geno Technology Description and Business Overview
6.10.3 Geno Technology Immunoprecipitation Testing Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Geno Technology Immunoprecipitation Testing Product Portfolio
6.10.5 Geno Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immunoprecipitation Testing Industry Chain Analysis
7.2 Immunoprecipitation Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immunoprecipitation Testing Production Mode & Process
7.4 Immunoprecipitation Testing Sales and Marketing
7.4.1 Immunoprecipitation Testing Sales Channels
7.4.2 Immunoprecipitation Testing Distributors
7.5 Immunoprecipitation Testing Customers
8 Immunoprecipitation Testing Market Dynamics
8.1 Immunoprecipitation Testing Industry Trends
8.2 Immunoprecipitation Testing Market Drivers
8.3 Immunoprecipitation Testing Market Challenges
8.4 Immunoprecipitation Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Thermo Fischer Scientific
Merck
GenScript
Bio-Techne
BioLegend
Takara Bio
Abcam
Rockland Immunochemicals
Cell Signaling Technology
Geno Technology
Ìý
Ìý
*If Applicable.